Seroreactive epitopes on proteins of human papillomavirus (hpv) 18
CA 2042236 C · Owner: Dade Behring Marburg Gmbh · Inventors: Gissmann, Lutz; Bleul, Conrad; Muller, Martin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to seroreactive epitopes on proteins of human papillomavirus HPV18. In addition the invention, relates to peptides which have amino-acid sequences which coincide in whole or in part with the sequences of the seroreactive epitopes, and to vaccines which contain such peptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 9, 1991 and granted July 9, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 9, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 9, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.